Global Rare Disease Diagnosis Will Fuel Biotech Market Expansion
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 8 Analysts
Published
29 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$23.22
59.3% undervalued intrinsic discount15 Aug
US$9.44
1Y
33.5%7D
2.6%